Competitor Analysis HIV Vaccines

Date: October 22, 2011
Pages: 54
US$ 413.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Competitor Analysis HIV Vaccines
Product description

The present Competitive Intelligence report about HIV Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines against human immunodeficiency virus (HIV). Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development for prophylaxis and therapy of human immunodeficiency virus (HIV) infection. In addition, the report lists company-specific R&D pipelines of HIV vaccines. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

  • DNA vaccines (plasmid, conventional, alternative delivery and prime – boost regimens)
  • Adenoviral vector vaccines
  • Poxvirus vector vaccines
  • Protein & peptide vaccines
  • Others
  • Corporate HIV Vaccine R&D Pipelines

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Skip to top

Competitor Analysis: Malaria Vaccines & Therapeutics US$ 390.00 Aug, 2012 · 64 pages
Competitor Analysis: RSV Vaccines and Therapeutics US$ 315.00 Jun, 2012 · 30 pages
Competitor Analysis: HPV Vaccines US$ 170.00 May, 2010 · 18 pages
Competitor Analysis: CMV Vaccines & Therapeutics US$ 247.00 Aug, 2012 · 23 pages

Ask Your Question

Competitor Analysis HIV Vaccines
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: